| |September 20174CIOReviewEditorial PublisherOffice Editorial queries editor@cioreviewindia.com To subscribeVisit www.cioreviewindia.com/magazine-in or send email to: subscription@cioreviewindia.comCover price is Rs 150 per issueAshok KumarVirupakshi PattarAlok ChaturvediCIOReviewSr. VisualizerGroup Art DirectorVP - Sales & MarketingMagendran PerumalCirculation ManagerEditorial TeamCIOReview No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugheshpalya, Bangalore-560017ManjunathMaitreyeeCIOReviewEditorSudhakar SinghVisualizerAdvertising queriessales@cioreviewindia.comBangaloreTel 080 46441103NoidaTel 120 4639300Sales & MarketingAmrit SinghIndranil ChakrabortyRavi Kalgi Rohit RaghubanshiSambit SatpathyPrinted and published by Alok Chaturvedi on Behalf of BizprintMedia Technologies Pvt Ltd and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published at No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2017 BizprintMedia Technologies Pvt Ltd, All rights reserved. Re-production in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.Aarushi GhaiAnitha TLakshmi GShaheen SaikiaVinisha PaivaPharmaceuticals and life sciences companies today are experiencing a diverse set of challenges. They include consolidation among providers, especially hospitals, intended to produce efficiency gains; the changing demands and expectations of patients, who seek a greater role in their own care; and the declining autonomy of the individual physician as rule-based, protocol-driven care becomes ascendant. The resulting healthcare system is going to focus increasingly on paying for the value rather than the volume of medical care. Some pharma companies are positioned to capitalize on this situation to demonstrate the clinical and economic value of their products and solutions in fresh ways. These companies have begun to adopt new technologies for data analytics that can manage and assess the results of personalized medicine delivery and determine the direction of product development. The companies are also reexamining the way they look at the value of their products and their pricing and distribution structures, while designing systems that let them communicate more effectively with patients and monitor outcomes. Due to advances in digital and medical technology, pharma companies and healthcare providers can access patient data seamlessly, in real time, and with little inconvenience for patients. An array of tools can be combined with online portals and mobile apps to foster better, more immediate communication. The pharma industry is at the early stages of a fundamental shift as so-called enterprise analytics and advanced data sciences are embedded across the value chain to influence business decision making at all levels. Pharma companies have begun to realize real benefits from this evolving data ecosystem, using new methods for rapid acquisition, curation, analysis, and visualization of large, diverse data sets in cloud-based storage and distributed computing power platforms. In this issue, CIOReview India presents to you 20 Most Promising Pharma and Life Sciences Tech Solution Providers who have successfully helped organizations with their innovative offerings. These companies pride themselves on keeping pace with the latest technological advancements in this segment. We hope this issue gives you helpful insight into this market landscape. Sudhakar SinghEditorsudhakar@cioreviewindia.comTechnology Making Its Way into Pharma and Life Sciences Industry VOL 5 · ISSUE 9-4 · SEPTEMBER 15, 2017 | |February 20175CIOReviewCombining Offline andOnline Channels
< Page 3 | Page 5 >